Prevalence and Predictors of Diabetic Retinopathy: A Community-Based Study in North India Among Type 2 Diabetes Patients
DOI:
https://doi.org/10.55489/njcm.161020255818Keywords:
Diabetic retinopathy, Prevalence, Risk factors, Diabetes mellitus, Fundus photoAbstract
Background: Between 1970-1975, DR was the 20th cause of blindness, and today, it is the 6th most common cause of blindness in India. This study aimed to estimate the prevalence of DR among type 2 diabetes patients and identify associated socio-demographic determinants.
Methods: Total of 316 type 2 diabetics patients through systematic random sampling were enrolled. Fundus examination was performed using Volk iNview iPhone fundus camera following ETDRS protocol. Data on demographics, anthropometric measurements, and clinical parameters were collected. Statistical analysis included chi-square tests and logistic regression to identify the risk factors.
Results: Prevalence of any grade of DR was 35.4% (95% CI: 30%-41.5%) which included mild non-proliferative (15.5%), moderate non-proliferative (11.7%), severe non-proliferative (3.8%), proliferative (1.6%), and diabetic macular edema (2.8%). Multivariate analysis identified significant independent risk factors: age >60 years (adjusted OR=1.11), diabetes duration >5 years (adjusted OR=1.20), uncontrolled glycemia (adjusted OR=2.25), hypertension (adjusted OR=1.04), previous cataract surgery (adjusted OR=1.76), and overweight/obesity (adjusted OR=1.202).
Conclusion: Predominance of early-stage disease highlights the opportunity for early intervention through community-based screening initiatives. The findings emphasize the importance of integrated diabetes management addressing multiple risk domains, particularly glycemic control, blood pressure management, and weight optimization, for effective DR prevention and management.
References
Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS. 10th ed. Brussels: International Diabetes Federation; 2021. PMID: 35914061.
International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels: International Diabetes Federation; 2019.
Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021;69(11):2932-2938. DOI: https://doi.org/10.4103/ijo.IJO_1627_21 PMid:34708726 PMCid:PMC8725109
Goyal R, Singhal M, Jialal I. Type 2 Diabetes. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513253/#_ncbi_dlg_citbx_NBK513253
World Health Organization. TADDS: Tool for Assessment of Diabetes and Diabetic Retinopathy. Geneva: World Health Organization; 2015. Available from: https://www.who.int/publications/i/item/tadds-tool-for-the-assessment-of-diabetic-retinopathy-and-diabetes-management-systems
Raman R, Ganesan S, Pal SS, Gella L, Kulothungan V, Sharma T. Incidence and progression of diabetic retinopathy in urban India: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II), Report 1. Ophthalmic Epidemiol. 2017;24(5):294-302. DOI: https://doi.org/10.1080/09286586.2017.1290257 PMid:28332894
Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self-reported diabetics in southern India: A population-based assessment. Br J Ophthalmol. 2002;86(9):1014-1018. DOI: https://doi.org/10.1136/bjo.86.9.1014 PMid:12185129 PMCid:PMC1771268
ETDRS Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classificationETDRS report number 10). Ophthalmology. 1991;98(5 Suppl):786-806. DOI: https://doi.org/10.1016/S0161-6420(13)38012-9 PMid:2062513
Reed J, Bain S, Kanamarlapudi V. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives. Diabetes Metab Syndr Obes. 2021 Aug 10;14:3567-3602. DOI: https://doi.org/10.2147/DMSO.S319895 PMid:34413662 PMCid:PMC8369920
Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: A population-based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J Epidemiol Community Health. 2000;54(3):173-177. DOI: https://doi.org/10.1136/jech.54.3.173 PMid:10746110 PMCid:PMC1731634
Brar AS, Sahoo J, Behera UC, Jonas JB, Sivaprasad S, Das T. Prevalence of diabetic retinopathy in urban and rural India: A systematic review and meta-analysis. Indian J Ophthalmol. 2022;70(6):1945-1955. DOI: https://doi.org/10.4103/ijo.IJO_2206_21 PMid:35647959 PMCid:PMC9359280
Raman R, Vasconcelos JC, Rajalakshmi R, et al. Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban-rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectional screening study. Lancet Glob Health. 2022;10(12):e1764-73. DOI: https://doi.org/10.1016/S2214-109X(22)00411-9 PMid:36327997
Ruth Colagiuri. International Diabetes Federation. A Guide to National Diabetes Programmes.Brussels: International Diabetes Federation; 2010. Available at: https://idf.org/media/uploads/2023/05/attachments-14.pdf
Alemu Mersha G, Alimaw YA, Woredekal AT, et al. Prevalence of diabetic retinopathy among diabetic patients in Northwest Ethiopia: A cross-sectional hospital-based study. PLoS One. 2022;17(1):e0262664. DOI: https://doi.org/10.1371/journal.pone.0262664 PMid:35061820 PMCid:PMC8782290
Sidda Naik B, Rama Lakshmi B, Bharathi B, et al. Prevalence of diabetic retinopathy: A hospital-based study. J Evid Based Med Healthc. 2020;7(2):73-78. DOI: https://doi.org/10.18410/jebmh/2020/16
Tang H, Luo N, Zhang X, Huang J, Yang Q, Lin H, Zhang X. Association between biological aging and diabetic retinopathy. Sci Rep. 2024 May 2;14(1):10123. DOI: https://doi.org/10.1038/s41598-024-60913-x. PMID: 38698194; PMCID: PMC11065862.
Preethi KS, Devatha S. The Severity of diabetic retinopathy and its relationship with duration of diabetes and hypertension. Int J Med Res Rev. 2024;12(4):93-98. doi:https://doi.org/10.17511/ijmrr.2024.i04.01
King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999 Nov;48(5):643-648. DOI: https://doi.org/10.1046/j.1365-2125.1999.00092.x PMid:10594464 PMCid:PMC2014359
The Diabetes Control and Complications Trial (DCCT) Research Group. Diabetes Control and Complications Trial (DCCT): Results of feasibility study. Diabetes Care. 1987;10(1):1-19. DOI: https://doi.org/10.2337/diacare.10.1.1 PMid:2882967
Roşu CD, Bratu ML, Stoicescu ER, Iacob R, Hațegan OA, Ghenciu LA, Bolintineanu SL. Cardiovascular risk factors as independent predictors of diabetic retinopathy in type II diabetes mellitus: The development of a predictive model. Medicina (Kaunas). 2024;60(10):1617. DOI: https://doi.org/10.3390/medicina60101617 PMid:39459404 PMCid:PMC11509873
Zhou Y, Zhang Y, Shi K, Wang C. Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review. Medicine (Baltimore). 2017 Jun;96(22):e6754. DOI: https://doi.org/10.1097/MD.0000000000006754 PMid:28562529 PMCid:PMC5459694
Liew G, Klein R, Wong TY. The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin. 2009;49(2):35-52. DOI: https://doi.org/10.1097/IIO.0b013e31819fd5d7 PMid:19349785 PMCid:PMC2746819
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mohd Yasir Zubair, Mohammad Athar Ansari, Ziya Siddiqui, Saira Mehnaz, Salman Khalil
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
